Pathogenesis of Keratin-Containing Inclusions in Liver Disease

肝脏疾病中含角蛋白包涵体的发病机制

基本信息

  • 批准号:
    7905576
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-05 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall goal of our studies is to understand the regulation, function, and disease association of the keratin intermediate filament (IF) cytoskeletal proteins in digestive organs. Keratins 8 and 18 (K8/K18) are the IFs of hepatocytes and their major function is cytoprotection from mechanical and nonmechanical stresses such as apoptosis. This function is consistent with the finding that specific K8 and K18 genetic variants predispose to liver disease progression. K8 and K18 are also the major constituents of Mallory body (MB) inclusions that are found in association with some liver diseases. Several transgenic animal studies demonstrated that K8 and a K8-greater-than-K18 protein ratio, coupled with a drug insult are all essential in order for MBs to form. MBs can be rapidly re-induced once initially formed but the mechanism of such rapid predisposition to reformation is unknown. Our proposal includes 4 aims to examine the pathogenesis of MBs. The first three aims test the hypothesis that keratin transamidation at specific amino acids is essential for MB formation. The 4th aim tests the hypothesis that chaperone function is altered during MB (re)formation. The proposed studies utilize cell culture and mouse MB models to help understand their pathogenesis and, ultimately, their importance in human disease. The 4 aims are: (i) Study MB formation in transglutaminase-2 (TG2) null and control mice using established in vivo models. This aim is based on our preliminary findings that TG2-null mice have a markedly blunted ability to form MBs. (ii) Identify keratin transamidation sites and their crosslinked partners in vivo/vitro and study their role in crosslinking and inclusion body formation in cell culture. This is based on the findings that K8/K18 are excellent TG2 substrates (K8>K18) in vitro, (iii) Generate transgenic mice that express transamidation-mutant keratins and test the effect of the mutations on MB formation and susceptibility to liver injury, (iv) Test the effect of MB-inducing injury on chaperone function and the potential role of chaperones as "memory proteins" in association with MB re-accumulation. This is based on our recent findings that MB formation correlates with chaperone dysfunction. Our proposed studies are likely to generate important new biologic and clinically relevant information regarding the pathogenesis of MBs. We anticipate that completion of this project will shed light on the specific keratin amino acids that allow MB formation and address if MBs are bystanders, protectors or promoters of injury. Our findings should also shed light on whether chaperone dysfunction can provide 'molecular memory" and as such contribute to rapid MB reformation. Our proposal represents a direct approach to fully understand the pathogenesis and significance of MBs that were first described in 1911 by Dr. Frank Mallory, and may also impact on other inclusions that are found in association with several other neurological and neuromuscular human diseases whose pathogenesis is unknown.
描述(由申请人提供):我们研究的总体目标是了解消化器官中角蛋白中间丝(IF)细胞骨架蛋白的调控、功能和疾病相关性。角蛋白8和18 (K8/K18)是肝细胞的干扰素,其主要功能是保护细胞免受机械和非机械应激(如凋亡)的影响。这一功能与特定的K8和K18基因变异易导致肝脏疾病进展的发现是一致的。K8和K18也是与某些肝脏疾病相关的Mallory小体(MB)内含物的主要成分。几项转基因动物研究表明,为了形成MBs, K8和K8-大于k18的蛋白质比例,加上药物损伤都是必不可少的。MBs一旦最初形成,可以迅速重新诱导,但这种快速重组倾向的机制尚不清楚。我们的提案包括4个目的来研究MBs的发病机制。前三个目的是测试特定氨基酸的角蛋白转氨化对MB形成至关重要的假设。第4个目的是验证在MB (re)形成过程中伴侣蛋白功能发生改变的假设。拟议的研究利用细胞培养和小鼠MB模型来帮助了解其发病机制,并最终了解其在人类疾病中的重要性。4个目标是:(i)使用已建立的体内模型研究转谷氨酰胺酶-2 (TG2)缺失和对照小鼠中MB的形成。这一目标是基于我们的初步发现,tg2缺失小鼠形成MBs的能力明显减弱。(ii)在体内/体外鉴定角蛋白转酰胺位点及其交联伙伴,并研究其在细胞培养中交联和包涵体形成中的作用。这是基于K8/K18在体外是优秀的TG2底物(K8>K18)的发现,(iii)产生表达转酰胺突变角蛋白的转基因小鼠,并测试突变对MB形成和肝损伤易感性的影响,(iv)测试MB诱导损伤对伴侣蛋白功能的影响以及伴侣蛋白作为“记忆蛋白”与MB再积累相关的潜在作用。这是基于我们最近的发现,MB的形成与伴侣功能障碍有关。我们提出的研究可能会产生关于MBs发病机制的重要的新的生物学和临床相关信息。我们预计,该项目的完成将揭示特定的角蛋白氨基酸,允许MB形成和解决MBs是旁观者,保护或促进损伤。我们的研究结果还揭示了伴侣功能障碍是否可以提供“分子记忆”,从而有助于MB的快速重组。我们的研究为充分理解Frank Mallory博士于1911年首次描述的MBs的发病机制和意义提供了一种直接的方法,也可能影响与其他几种发病机制未知的神经和神经肌肉疾病相关的其他包涵体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bishr Omary其他文献

Bishr Omary的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bishr Omary', 18)}}的其他基金

Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
卟啉症的蛋白质毒性机制和实验治疗方法
  • 批准号:
    9469835
  • 财政年份:
    2017
  • 资助金额:
    $ 10万
  • 项目类别:
Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
卟啉症的蛋白质毒性机制和实验治疗方法
  • 批准号:
    10445775
  • 财政年份:
    2017
  • 资助金额:
    $ 10万
  • 项目类别:
Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
卟啉症的蛋白质毒性机制和实验治疗方法
  • 批准号:
    9753724
  • 财政年份:
    2017
  • 资助金额:
    $ 10万
  • 项目类别:
Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
卟啉症的蛋白质毒性机制和实验治疗方法
  • 批准号:
    10588162
  • 财政年份:
    2017
  • 资助金额:
    $ 10万
  • 项目类别:
Michigan IRACDA: Training Future Professors of Engineering and Physiology
密歇根 IRACDA:培训未来的工程和生理学教授
  • 批准号:
    9900910
  • 财政年份:
    2016
  • 资助金额:
    $ 10万
  • 项目类别:
Michigan IRACDA: Training Future Professors of Engineering and Physiology
密歇根 IRACDA:培训未来的工程和生理学教授
  • 批准号:
    9324272
  • 财政年份:
    2016
  • 资助金额:
    $ 10万
  • 项目类别:
Genetic influences in experimental pancreatitis
实验性胰腺炎的遗传影响
  • 批准号:
    8597923
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Genetic influences in experimental pancreatitis
实验性胰腺炎的遗传影响
  • 批准号:
    8965966
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Genetic influences in experimental pancreatitis
实验性胰腺炎的遗传影响
  • 批准号:
    8244910
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:
Genetic influences in experimental pancreatitis
实验性胰腺炎的遗传影响
  • 批准号:
    8762421
  • 财政年份:
    2012
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了